ABVC BioPharma vs Allarity Therapeutics
ABVC BioPharma reported revenue of $0 million in fiscal 2025, about the same as Allarity Therapeutics' $0 million in fiscal 2025. ABVC BioPharma had an operating margin of -2416.0%, against -3939.1% at Allarity Therapeutics.
Side by side
| ABVC BioPharma | Allarity Therapeutics | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $0M | $0M |
| Revenue growth | −41.9% | — |
| Revenue growth a year, last 5 years | −9.7% | — |
| Gross margin | — | — |
| Operating margin | −2,416.0% | −3,939.1% |
| Net margin | −2,671.8% | −3,509.7% |
| Free cash flow | — | −$15M |
| Free cash flow margin | — | −4,633.8% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $3M |
| Change in diluted share count | 72.2% | 794.8% |
| Last close | $0.88 | $0.86 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | — | — |
| Piotroski F-score | — | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
ABVC BioPharmaAllarity Therapeutics
Operating margin
Percent of revenue
ABVC BioPharmaAllarity Therapeutics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ABVC BioPharmaAllarity Therapeutics
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the ABVC BioPharma and Allarity Therapeutics pages.